Alder Hey Children's Hospital NHS Foundation Trust to Deploy e-Prescribing Solution from JAC

JAC, the UK's leading medicine management systems specialist, has won a contract with Alder Hey Children's NHS Foundation Trust to undertake a trust-wide roll out of its Electronic Prescribing and Medicines Administration (EPMA) system.

As one of Europe's biggest children's hospitals, Alder Hey provides care for over 200,000 children each year, and the Trust's services are present in more than 40 community outreach sites and programmes. The new EPMA system will help staff ensure the quality and accuracy of prescribing and eliminate drug transcription errors, as well as giving Alder Hey improved access to medication and administration records.

Paediatric prescribing is often complex due to drug dose levels often needing to be altered regularly due to the age and weight of patients whose parameters often change more rapidly than adult scenarios. This requires clinicians to consider many different variables to ensure the correct dose is administered. The JAC solution is able to cater for Alder Hey's key paediatric requirements, ensuring critical variables, such as weight and body surface area are included when calculating doses for each individual child.

The EPMA system will also accelerate the distribution of discharge summaries to GPs and provide clinicians with an effective method for monitoring prescribing habits against Trust protocol.

Heather Swanston, EPS Project Manager at Alder Hey Children's NHS Foundation Trust said: "JAC's EPMA solution will provide staff with closer management of prescriptions and will be key in streamlining the prescribing process by reducing the amount of data entry involved. The system will also help to improve patient safety, eliminate errors, and allow Alder Hey to undertake extensive reporting and patient level costing for better financial management."

Alder Hey went through a tendering process and selected JAC's e-prescribing solution for its rich functionality, and ability to fully integrate with the Trust's existing JAC stock control system. The benefits of this approach includes reducing administration overheads, transcription errors and providing a Trust wide unified drug database.

E-prescribing functionality will be first rolled out to both inpatient and outpatient wards, with the intention of extending the outreach to the Trust's community sites in the future.

In addition to enhancing compliance and reducing errors, e-prescribing can deliver savings in drug costs through closer management of prescriptions, and can cut the time taken to discharge patients by reducing waiting times for take-out medication, helping to free up beds. It also gives comprehensive audit trails for prescribing and medicines administration, improving clinical governance.

The system also incorporates First DataBank Europe's Multilex Drug Data File, which provides clinical users with patient-specific clinical decision support.

About JAC
JAC is the UK's leading medicine management systems specialist, with the largest installed base of Electronic Prescribing and Medicines Administration systems in UK hospitals. These systems improve patient safety by reducing prescribing and administration mistakes that could result in medication errors and adverse drug events.

EPMA also facilitates wider improvements in clinical practice, including: reductions in paperwork and transcriptions; improved audit trails for medication; performance monitoring and intelligence; reporting greater consistency and continuity of care between primary and secondary care settings; and more effective communication between hospital departments and pharmacies. The system incorporates the UK's leading Clinical drug database (FirstDatabank Multilex), to support safe and effective electronic prescribing through its clinical checking, reducing the risk of medication errors and increasing patient safety.

http://www.jac-pharmacy.co.uk

Most Popular Now

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...